SCHEMBL7669407

SCHEMBL7669407

CS(=O)(=O)n1ccc2c1C=C1C(C#N)CC1C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7669410 0.65
SCHEMBL6582959 0.62 HTR6 (0.40)
SCHEMBL6984945 0.62 HTR6 (0.39)
SCHEMBL7525942 0.59
SCHEMBL16530109 0.51 HTR6 (0.39)
SCHEMBL22130656 0.49 ELAVL1 (0.49)
SCHEMBL8564926 0.49 CRBN (0.52)
SCHEMBL26816689 0.49 HTR6 (0.39)
SCHEMBL28875610 0.49 HTR6 (0.52)
SCHEMBL29179093 0.48 PTGS2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6452015-B2 FOR TREATMENT OF ANXIETY, PANIC ATTACKS, OBSESSIVE-COMPULSIVE DISORDERS, PHOBIAS, IMPULSIVE DISORDERS, DRUG ABUSE, COGNITIVE DISORDERS, PSYCHOSES, DEPRESSION AND MOOD DISORDERS LES LABORATOIRES SERVIER (FR) 2002-09-17 US disclosed